Is a Functional Cure for Type 1 Diabetes on the Horizon?

Have you heard about the ongoing research on cell-based therapies for type 1 diabetes? Dr. Paul Laikind is the President and CEO of ViaCyte, a company that aims to develop “a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence.” Hear more about the novel research and the recent […]
Source: diabetesdaily.com

Search

+